Keep up to date
- Press release | 11.01.2019
Univercells introduces breakthrough vaccine manufacturing platform
Univercells announces today the commercial launch of its proprietary NevoLine™ bioproduction system for vaccines.
- In the press | 01.11.2018
Scaling up Novel Therapies
Our Product Manager Alex chatel and other peers from the industry discuss about technologies used to improve scale-up and the challenges ...
- Univercells news | 10.09.2018
Univercells welcomes Pierre Morgon as member of the Board of Directors
Dr. Pierre Morgon brings his notable experience and extensive industry knowledge to reinforce Univercells’ business strategy and ...
- In the press | 21.08.2018
Hugues Bultot, CEO of Univercells (French)
- Press release | 16.07.2018
Univercells raises €16 million in Series B financing round led by Global Health Investment Fund
Investment proceeds will support commercialization of the company’s breakthrough biologics manufacturing technology
- Univercells news | 09.07.2018
Univercells presents preliminary data from its Polio vaccine production platform
Data demonstrates how its micro-facility can achieve a 10-fold reduction in Polio vaccine manufacturing costs
- Univercells news | 25.06.2018
Univercells appoints Christian Borgniet as Chief Operating Officer
Announcing Christian Borgniet, our new COO, bringing to the table his twenty-five years of broad industry experience and knowledge garnered ...
- Univercells news | 16.05.2018
Univercells hits the ground running with new Equipment Design Center
Due to burgeoning development at its Gosselies facility creating the need for more space, Univercells has expanded its activities to ...
Download Univercells company profile, logo, and picturesPress kit
Belgium Press Inquiries
Univercells - Marketing & Communication email@example.com
International Press Inquiries
Andrew Lloyd & Associates - Juliette Dos Santosjuliette@ala.com